• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性帕金森病患者来源的中脑细胞类体中Lewy 体样病理学和多巴胺能神经元丧失

Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson's Disease Patient.

机构信息

Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

出版信息

Cells. 2023 Feb 15;12(4):625. doi: 10.3390/cells12040625.

DOI:10.3390/cells12040625
PMID:36831291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9954141/
Abstract

Progressive accumulation of α-Synuclein (αSyn) in Lewy bodies (LBs) and loss of dopaminergic (DA) neurons are the hallmark pathological features of Parkinson's disease (PD). Although currently available in vitro and in vivo models have provided crucial information about PD pathogenesis, the mechanistic link between the progressive accumulation of αSyn into LBs and the loss of DA neurons is still unclear. To address this, it is critical to model LB formation and DA neuron loss, the two key neuropathological aspects of PD, in a relevant in vitro system. In this study, we developed a human midbrain-like organoid (hMBO) model of PD. We demonstrated that hMBOs generated from induced pluripotent stem cells (hiPSCs), derived from a familial PD (fPD) patient carrying αSyn gene () triplication accumulate pathological αSyn over time. These cytoplasmic inclusions spatially and morphologically resembled diverse stages of LB formation and were composed of key markers of LBs. Importantly, the progressive accumulation of pathological αSyn was paralleled by the loss of DA neurons and elevated apoptosis. The model developed in this study will complement the existing in vitro models of PD and will provide a unique platform to study the spatiotemporal events governing LB formation and their relation with neurodegeneration. Furthermore, this model will also be beneficial for in vitro screening and the development of therapeutic compounds.

摘要

α-突触核蛋白(αSyn)在路易体(LB)中的逐渐积累和多巴胺能(DA)神经元的丧失是帕金森病(PD)的标志性病理特征。尽管目前可用的体外和体内模型提供了有关 PD 发病机制的重要信息,但 αSyn 逐渐积累到 LB 中和 DA 神经元丧失之间的机制联系仍不清楚。为了解决这个问题,在相关的体外系统中对 LB 形成和 DA 神经元丧失这两个 PD 的关键神经病理学方面进行建模至关重要。在这项研究中,我们开发了一种 PD 的人类中脑细胞类器官(hMBO)模型。我们证明了源自携带 αSyn 基因()三重复制的家族性 PD(fPD)患者的诱导多能干细胞(hiPSC)生成的 hMBO 随着时间的推移会积累病理性 αSyn。这些细胞质内含物在空间和形态上类似于 LB 形成的不同阶段,并且由 LB 的关键标志物组成。重要的是,病理性 αSyn 的逐渐积累伴随着 DA 神经元的丧失和凋亡的增加。本研究中开发的模型将补充现有的 PD 体外模型,并为研究控制 LB 形成的时空事件及其与神经退行性变的关系提供独特的平台。此外,该模型也有利于体外筛选和治疗化合物的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/449463bb920c/cells-12-00625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/ad23ce1474e0/cells-12-00625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/1011567c8275/cells-12-00625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/d306483a1046/cells-12-00625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/984b2c230413/cells-12-00625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/7f8ff62529f3/cells-12-00625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/449463bb920c/cells-12-00625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/ad23ce1474e0/cells-12-00625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/1011567c8275/cells-12-00625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/d306483a1046/cells-12-00625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/984b2c230413/cells-12-00625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/7f8ff62529f3/cells-12-00625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/9954141/449463bb920c/cells-12-00625-g006.jpg

相似文献

1
Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson's Disease Patient.家族性帕金森病患者来源的中脑细胞类体中Lewy 体样病理学和多巴胺能神经元丧失
Cells. 2023 Feb 15;12(4):625. doi: 10.3390/cells12040625.
2
Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.帕金森病患者(PARK4)中 SNCA 三重复制诱导多能干细胞源性多巴胺能神经元中的α-突触核蛋白动力学。
FEBS Open Bio. 2021 Feb;11(2):354-366. doi: 10.1002/2211-5463.13060. Epub 2021 Jan 5.
3
Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.家族性帕金森病患者诱导多能干细胞衍生的多巴胺能神经元显示α-突触核蛋白病理学和异常的线粒体形态。
Cells. 2021 Sep 13;10(9):2402. doi: 10.3390/cells10092402.
4
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.MHC 类 II 转录激活因子调节帕金森病体内大鼠模型中种子化的α-突触核蛋白病理和多巴胺能神经退行性变。
Brain Behav Immun. 2021 Jan;91:369-382. doi: 10.1016/j.bbi.2020.10.017. Epub 2020 Oct 22.
5
Neuropathology of α-synuclein in Parkinson's disease.帕金森病中α-突触核蛋白的神经病理学。
Neuropathology. 2022 Apr;42(2):93-103. doi: 10.1111/neup.12812. Epub 2022 Mar 31.
6
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.β-葡萄糖脑苷脂酶的激活可减少帕金森病患者中脑神经元的病理性α-突触核蛋白并恢复溶酶体功能。
J Neurosci. 2016 Jul 20;36(29):7693-706. doi: 10.1523/JNEUROSCI.0628-16.2016.
7
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.半乳糖凝集素-3 塑造帕金森病中的毒性α-突触核蛋白菌株。
Acta Neuropathol. 2023 Jul;146(1):51-75. doi: 10.1007/s00401-023-02585-x. Epub 2023 May 18.
8
Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.内皮细胞 LRP1-ICD 通过激活 PARP1 加速帕金森病小鼠模型中与认知相关的α-突触核蛋白病理和神经退行性变。
Mol Neurobiol. 2023 Feb;60(2):979-1003. doi: 10.1007/s12035-022-03119-4. Epub 2022 Nov 17.
9
The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.α-突触核蛋白和 parkin 在神经元细胞凋亡中的调节作用;对帕金森病发病机制的可能影响。
Apoptosis. 2010 Nov;15(11):1312-21. doi: 10.1007/s10495-010-0486-8.
10
Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications.利用一组具有 SNCA 多重扩增的新型同基因 iPSC 系,对多巴胺能神经元中原发性和播种的突触核蛋白聚集及相关细胞功能障碍进行建模。
Cell Death Dis. 2022 Oct 19;13(10):881. doi: 10.1038/s41419-022-05330-6.

引用本文的文献

1
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.帕金森病:弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
2
Distinct microRNA signatures define sporadic PSP-RS and PD in patient-derived midbrain organoids.独特的微小RNA特征在源自患者的中脑类器官中区分散发性进行性核上性麻痹和帕金森病。
iScience. 2025 Jul 18;28(8):113162. doi: 10.1016/j.isci.2025.113162. eCollection 2025 Aug 15.
3
From copper homeostasis to cuproptosis: a new perspective on CNS immune regulation and neurodegenerative diseases.

本文引用的文献

1
Protocol for controlled cortical impact in human cerebral organoids to model traumatic brain injury.人类类脑器官控制性皮质撞击协议,用于创伤性脑损伤建模。
STAR Protoc. 2021 Dec 4;2(4):100987. doi: 10.1016/j.xpro.2021.100987. eCollection 2021 Dec 17.
2
Modeling Traumatic Brain Injury in Human Cerebral Organoids.在人类类脑器官中模拟创伤性脑损伤。
Cells. 2021 Oct 7;10(10):2683. doi: 10.3390/cells10102683.
3
Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
从铜稳态到铜死亡:中枢神经系统免疫调节和神经退行性疾病的新视角
Front Neurol. 2025 May 29;16:1581045. doi: 10.3389/fneur.2025.1581045. eCollection 2025.
4
The current approaches to modeling the brain ischemia-reperfusion and inflammation: from animal models toward vascularized and neuroimmune cerebral organoids.目前模拟脑缺血再灌注和炎症的方法:从动物模型到血管化和神经免疫性脑类器官。
Rev Neurosci. 2025 May 28. doi: 10.1515/revneuro-2025-0015.
5
Ginsenoside Rg1 in Parkinson's disease: from basic research to clinical applications.人参皂苷Rg1在帕金森病中的应用:从基础研究到临床应用
Front Pharmacol. 2025 Apr 16;16:1490480. doi: 10.3389/fphar.2025.1490480. eCollection 2025.
6
The potential of brain organoids in addressing the heterogeneity of synucleinopathies.脑类器官在解决突触核蛋白病异质性方面的潜力。
Cell Mol Life Sci. 2025 Apr 28;82(1):188. doi: 10.1007/s00018-025-05686-w.
7
Research models to study lewy body dementia.用于研究路易体痴呆的研究模型。
Mol Neurodegener. 2025 Apr 23;20(1):46. doi: 10.1186/s13024-025-00837-w.
8
Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids: Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery.在3D中脑类器官中模拟散发性进行性核上性麻痹:重现疾病特征以用于体外诊断和药物发现
Ann Neurol. 2025 May;97(5):845-859. doi: 10.1002/ana.27172. Epub 2025 Jan 28.
9
Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine.网络药理学在中医药治疗神经退行性疾病中的应用
Planta Med. 2025 Apr;91(5):226-237. doi: 10.1055/a-2512-8928. Epub 2025 Jan 8.
10
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.人源中脑类器官:用于帕金森病高级建模和治疗探索的强大工具。
NPJ Parkinsons Dis. 2024 Oct 20;10(1):189. doi: 10.1038/s41531-024-00799-8.
家族性帕金森病患者诱导多能干细胞衍生的多巴胺能神经元显示α-突触核蛋白病理学和异常的线粒体形态。
Cells. 2021 Sep 13;10(9):2402. doi: 10.3390/cells10092402.
4
Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.脑类器官的优化:阿尔茨海默病研究更具资质的模型。
Transl Neurodegener. 2021 Aug 9;10(1):27. doi: 10.1186/s40035-021-00252-3.
5
Lewy Body-like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α-Synuclein Mutations.携带葡萄糖脑苷脂酶和 α-突触核蛋白突变的人类中脑类器官中的路易体样包含物。
Ann Neurol. 2021 Sep;90(3):490-505. doi: 10.1002/ana.26166. Epub 2021 Aug 10.
6
Generation of caudal-type serotonin neurons and hindbrain-fate organoids from hPSCs.从人多能干细胞生成尾型 5-羟色胺神经元和后脑命运类器官。
Stem Cell Reports. 2021 Aug 10;16(8):1938-1952. doi: 10.1016/j.stemcr.2021.06.006. Epub 2021 Jul 8.
7
Modelling Parkinson's Disease: iPSCs towards Better Understanding of Human Pathology.帕金森病建模:诱导多能干细胞助力深入了解人类病理学
Brain Sci. 2021 Mar 14;11(3):373. doi: 10.3390/brainsci11030373.
8
Long-term maturation of human cortical organoids matches key early postnatal transitions.人类皮质类器官的长期成熟过程与关键的早期产后发育转变相匹配。
Nat Neurosci. 2021 Mar;24(3):331-342. doi: 10.1038/s41593-021-00802-y. Epub 2021 Feb 22.
9
Generation and long-term culture of advanced cerebral organoids for studying later stages of neural development.用于研究神经发育后期阶段的高级脑类器官的生成与长期培养。
Nat Protoc. 2021 Feb;16(2):579-602. doi: 10.1038/s41596-020-00433-w. Epub 2020 Dec 16.
10
Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo.脑类器官:体外与体内研究人类神经生物学的接口
Nat Neurosci. 2020 Dec;23(12):1496-1508. doi: 10.1038/s41593-020-00730-3. Epub 2020 Nov 2.